MorphoSys GmbH
- ISIN DE0006632003
- Country Deutschland
Company profile
At MorphoSys (FSE & NASDAQ: MOR) we are driven by our mission to give more life for people with cancer. As a global commercial-stage biopharmaceutical company, we use groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts. To learn more, visit us at www.morphosys.com